A common variant in MTHFR influences response to chemoradiotherapy and recurrence of rectal cancer.

Nikas, Jason B; Lee, Janet T; Maring, Elizabeth D; Washechek-Aletto, Jill; Felmlee-Devine, Donna; Johnson, Ruth A; Smyrk, Thomas C; Tawadros, Patrick S; Boardman, Lisa A; Steer, Clifford J.

Nikas JB; Genomix Inc. Minneapolis, MN, USA.
Lee JT; Department of Surgery, University of Minnesota Minneapolis, MN, USA.
Maring ED; Department of Genetics, Cell Biology & Development, University of Minnesota Minneapolis, MN, USA.
Washechek-Aletto J; Department of Gastroenterology & Hepatology, Mayo Clinic Rochester, MN, USA.
Felmlee-Devine D; Department of Gastroenterology & Hepatology, Mayo Clinic Rochester, MN, USA.
Johnson RA; Department of Laboratory Medicine & Pathology, Mayo Clinic Rochester, MN, USA.
Smyrk TC; Department of Laboratory Medicine & Pathology, Mayo Clinic Rochester, MN, USA.
Tawadros PS; Department of Surgery, University of Minnesota Minneapolis, MN, USA.
Boardman LA; Department of Gastroenterology & Hepatology, Mayo Clinic Rochester, MN, USA.
Steer CJ; Department of Genetics, Cell Biology & Development, University of Minnesota Minneapolis, MN, USA ; Department of Medicine, University of Minnesota Minneapolis, MN, USA.

Am J Cancer Res ; 5(10): 3231-40, 2015.

Article en En | MEDLINE | ID: mdl-26693073

Palabras clave

MTHFR single nucleotide polymorphism; Rectal cancer; genetic variation; personalized medicine; recurrence of rectal cancer; response to chemoradiotherapy

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2015 Tipo del documento: Article